Diagnostic performance of 18F-FDG PET/CT and whole-body diffusion-weighted imaging with background body suppression (DWIBS) in detection of lymph node and bone metastases from pediatric neuroblastoma-Reference-Cited by-同舟云学术

Diagnostic performance of 18F-FDG PET/CT and whole-body diffusion-weighted imaging with background body suppression (DWIBS) in detection of lymph node and bone metastases from pediatric neuroblastoma

Published:2018-04-17 Issue:5 Volume:32 Page:348-362
ISSN:0914-7187
Container-title:Annals of Nuclear Medicine
language:en
Short-container-title:Ann Nucl Med

Author:

Ishiguchi Hiroaki,Ito Shinji,Kato Katsuhiko^ORCID,Sakurai Yusuke,Kawai Hisashi,Fujita Naotoshi,Abe Shinji,Narita Atsushi,Nishio Nobuhiro,Muramatsu Hideki,Takahashi Yoshiyuki,Naganawa Shinji

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/article/10.1007/s12149-018-1254-z/fulltext.html

Reference27 articles.

1. Haase GM, Perez C, Atkinsn JB. Current aspects of biopsy, risk assessment, and treatment of neuroblastoma. Semin Surg Oncol. 1999;16:91–104.

2. Maris JM. Recent advances in neuroblastoma. N Engl J Med. 2010;362:2202–11.

3. Kumar R, Shandal V, Shamim SA, Halanaik D, Malhotra A. Clinical applications of PET and PET/CT in pediatric malignancies. Expert Rev Anticancer Ther. 2010;10:755–68.

4. Kushner BH, Yeung HW, Larson SM, Kramer K, Cheung NK. Extending positron emission tomography scan utility to high-risk neuroblastoma: fluorine-18 fluorodeoxyglucose positron emission tomography as sole imaging modality in follow-up of patients. J Clin Oncol. 2001;19:3397–405.

5. Sharp SE, Shulkin BL, Gelfand MJ, Salisbury S, Furman WL. 123I-MIBG scintigraphy and 18F-FDG PET in neuroblastoma. J Nucl Med. 2009;50:1237–43.

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the Value of <sup>18</sup>F-FDG PET/CT in the Diagnosis and Treatment of Neuroblastoma;Advances in Clinical Medicine;2024

2. Comparison between whole‐body magnetic resonance imaging and whole‐body metaiodobenzylguanidine scintigraphy in the evaluation of primary tumor and metastases in neuroblastoma;Pediatric Blood & Cancer;2023-12-28

3. Whole-body three-dimensional short tau inversion recovery and T1-weighted in/opposed phase MRI in the detection of neuroblastoma bone marrow metastasis: comparative study with PET/CT utilising bone marrow biopsy as the reference standard;Clinical Radiology;2023-07

4. Clinical value of 18F-FDG PET/CT to predict MYCN gene, chromosome 1p36 and 11q status in pediatric neuroblastoma and ganglioneuroblastoma;Frontiers in Oncology;2023-03-24

5. Diagnostic Value of Diffusion-Weighted Imaging with Background Body Signal Suppression (DWIBS) for the Pre-Therapeutic Loco-Regional Staging of Cervical Cancer: A Feasibility and Interobserver Reliability Study;Current Oncology;2023-01-13